Search

everythinglearnresearchcommunity

for

Search:↓

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

PRP is popular for hair restoration but needs better research methods to confirm its effectiveness and safety.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Melatonin may help treat PCOS symptoms in rats.

Foxi3 expression in developing teeth and hair is controlled by the ectodysplasin pathway.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Women with PCOS have more emotional and body image issues than healthy women.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Intense Pulse Light effectively reduces hair growth in faun tail nevus.

Most diabetic patients have skin problems, which are more common with longer diabetes duration and poor blood sugar control.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Modified keratin binds better to hair, especially bleached hair.